Clinical Trials Browser

Carcinoma, Lobular × neratinib × 1 year × Clear all

NCT05919108 2025-09-09

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Phase 2 Recruiting

Carcinoma, Lobular